MBX Biosciences, Inc. Common Stock (MBX) Earnings Per Share (EPS)
MBX Biosciences, Inc. Common Stock (MBX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2022-12-31 | -$39.18 |
| 2023-12-31 | -$31.96 |
| 2024-12-31 | -$5.82 |
| 2025-12-31 | -$2.38 |
How MBX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| VTGN | Vistagen Therapeutics Inc. | -$1.83 |
| RCKT | Rocket Pharmaceuticals Inc. | -$2.01 |
| VYGR | Voyager Therapeutics Inc. | -$2.04 |
| IONS | Ionis Pharmaceuticals Inc. | -$2.38 |
| QTRX | Quanterix Corporation | -$2.51 |
These are five companies in the same sector as MBX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get MBX Biosciences, Inc. Common Stock Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("MBX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MBX | $68.25 | -0.47% | 0.46M |
| 3 | ||||
| 4 | ||||
| 5 |